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doi:10.1016/j.ejvs.2011.04.016Abstract Objectives: Aneurysms associated with congenital vascular malformation (CVM)
comprise critical complication. We review our experience with extracranial CVM-associated
aneurysms and attempt to clarify their clinical features.
Patients and methods: The prevalence, site, size and morphology of the accompanying aneu-
rysms of 48 consecutive CVM patients, who were managed at our hospital from 1999 to 2008,
were evaluated. After diagnosis or treatment, the patients were followed up, and the recur-
rence of aneurysms and patient survival were assessed.
Results: CVM-associated aneurysms were found in 14 patients (29%). CVMs were classified accord-
ing to the Hamburg classification. The patientswere classified into groups as follows: four (31%), in
the ‘predominantly arteriovenous (AV) shunting defect type’; eight (47%), ‘combined vascular
defects þ predominantly AV shunting defects type’; and two (11%), ‘combined vascular defects
type’. All aneurysms except one situated at the CVM were saccular, whereas nine were fusiform
aneurysms; all the ruptured aneurysms and seven out of the nine enlarging aneurysms were
saccular. Surgical treatment was performed 8 times in six patients. During the postoperative
follow-up period, recurrence and an aneurysm rupture were encountered in one patient each.
Conclusion: Aneurysm is not a rare complication of CVM. It is important to treat CVM before the
emergency presents. In addition to the treatment for malformation, regular screening for and
proper management of the aneurysms in CVM patients are indispensable.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Congenital vascular malformation (CVM) is a relatively
rare disease. It can occur anywhere in the body, including
the cranium, face, abdomen or extremities, and can be
potentially limb- or life threatening. Congestive heart
failure (CHF) could be induced in the presence of5800 8653; fax: þ81 3 3811 6822
.ac.jp (T. Miyata).
ty for Vascular Surgery. Publishearteriovenous (AV) shunts because of increased cardiac
output. Major bleeding is also one of the severe compli-
cations. Patients also complain of brush or mass lesions,
leg-length differences, venous stasis symptoms and cuta-
neous ulcers..
d by Elsevier Ltd. All rights reserved.
518 J. Suzuki et al.The treatment strategy for CVM should focus on both the
malformation and the secondary disorders. The goal of CVM
treatment, especially for the extra-truncular type origi-
nating at the early stage of embryogenesis, should be
complete destruction of the nidus that retains the mesen-
chymal cell characteristics. This includes occlusion of the
nidas and fistura or surgery followed by sclerotherapy using
ethanol to destroy the nidus and its mesenchymal cells to
eliminate the risk of recurrence. Ligation of feeding vessels
alone results in the enlargement of numerous smaller
feeding and draining vessels.1 However, aggressive treat-
ment of CVM in the limb always carries a risk of limb loss.
Although a critical complication, CVM-associated aneu-
rysms have infrequently been described.2 After experi-
encing a few cases of aneurysm rupture associated with
extracranial aneurysm rupture, we reviewed our experi-
ence and attempt to clarify its clinical features.
Patients and Methods
We reviewed 48 consecutive patients with extracranial
CVM, who were managed at the University of Tokyo Hospital
from 1999 to 2008. We diagnosed CVM in the patients on the
basis of clinical presentations and/or computed tomog-
raphy (CT), magnetic resonance imaging (MRI) and/or
conventional angiography. CVMs were classified according
to the Hamburg classification (Table 1)3 of vascular anom-
alies and malformations. Aneurysmal lesions were defined
as follows: (1) saccular-form proptosis and (2) dilatation
more than twice the normal size. We evaluated theTable 1 (A) Hamburg Classificationa,6-of congenital
vascular malformations (CVM) e types; (B) Hamburg Clas-
sification of CVMb: forms e embryological subtypes.
(A)
Predominantly arterial defects
Predominantly venous defects
Predominantly arteriovenous (AV) shunting defects
Predominantly lymphatic defects
Combined vascular defects
(B)
Extratruncular forms
Infiltrating, diffuse
Limited, localized
Truncular forms
Aplasia or obstruction
Hypoplasia, aplasia, hyperplasia
Stenosis, membrane, congenital spur
Dilation
Localized (aneurysm)
Diffuse (ectasia)
a Based on the consensus on CVM through the International
Workshop in Hamburg, Germany, 1988, and subsequently
modified -Capillary malformation was not included Develop-
mental arrest at the different stages of embryonic life: earlier
stage e extratruncular form; later stage e truncular form.
b Both forms may exist together; may be combined with other
various malformations (e.g. capillary, arterial, AV shunting,
venous, haemolymphatic, and/or lymphatic); and/or may exist
with haemangioma.prevalence, site, size and morphology of the aneurysm
accompanying the CVM. We then assessed the growth or
recurrence of the aneurysm as well as patient survival
during the follow-up period; the follow-up visits were
conducted in an outpatient clinic once or twice a year.
Results
During the study, 48 patients (24 men and 24 women) with
a mean age (SD) of 37.1 (17.9) years at the initial visit were
diagnosed with extracranial CVM, that were located in the
body trunk in nine patients, in the upper extremity in 14
(right, seven; left, seven) and in the lower extremity in 31
(right, 16; left, 15). Multiple lesions were detected in five
patients: in the body trunk and left-lower extremity in two,
in the body trunk and right-lower extremity in one patient,
in the bilateral lower extremities in one and in the body
trunk and both right upper and lower extremities in one.
Fourteen patients (29%) had CVM-associated aneurysms. Of
these 14 patients, two (14%) exhibited New York Heart
Association (NYHA) grade III CHF. On the contrary, 34
patients without aneurysms did not show any signs of CHF.
Each CVM was classified according to the Hamburg classi-
fication (Table 2). The patients with aneurysms were clas-
sified into the following groups: four (31%) patients in the
‘predominantly AV shunting defects type’; eight (47%),
‘combined vascular defects þ predominantly AV shunting
defects type’; and two (11%), ‘combined vascular defects
type’. As per this classification, ParkeseWeber syndrome
(PWS) can be included in the ‘combined vascular
defects þ predominantly AV shunting defects type’,Table 2 Patient characteristics.
Gender (male:female) 24:24
Age (years) 37.1 (range, 2e82)
Mean follow-up period
(months)
35.5 (range, 1e146)
Lesion of CVM
Upper extremity
(right:left)
7:7d
Lower extremity
(right:left)
16:15d
Body trunk 9d
CVM type (Hamburg
classification)
AV shuntinga 13 (4 aneurysms, 31% and
1 heart failure)
Combined þ AV shuntingb 17 (8 aneurysms, 47% and
1 heart failure)
Combined typec 18 (2 aneurysms, 11% and
no heart failure)
a Predominantly arteriovenous (AV) shunting defects type in
Humburg Classification.
b Combined vascular defects þ predominantly AV shunting
defects type in Humburg Classification.
c Combined vascular defects type in Humburg Classification.
d Duplicative lesions of the body trunk and left-lower
extremity in 2 patients; body trunk and right-lower extremity
in 1; bilateral lower extremity in 1; and body trunk, and right-
upper and right-lower extremities in 1.
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included in the ‘combined vascular defects type’. In each
of the ‘predominantly AV shunting defects type’ and the
‘combined vascular defects þ predominantly AV shunting
defects type’, one patient was found to have CHF.
The demographic data of the patients with aneurysms
are shown in Table 3. Fourteen patients had a total of 24
aneurysms, of which all but one was situated at the CVM.
There were 15 saccular and nine fusiform aneurysms; all
the ruptured aneurysms and seven out of the nine enlarging
aneurysms were saccular in shape.
Our indications for surgery for CVM complicated by
aneurysm were as follows: (1) a ruptured or an impending
ruptured aneurysm, (2) an aneurysm enlarging during the
follow-up, (3) an aneurysm with the risk of distal embolism
with endovascular treatment and (4) CHF or uncontrollable
bleeding expected to improve upon closure of the AV shunt.
Surgical treatment was performed 8 times in six patients
(patients #1e#6). During the postoperative follow-up
period, recurrence and an aneurysm rupture was encoun-
tered in one patient each.Table 3 The patients with the aneurysm associated with CVM.
Patient No.
(admission
number)
Age,
Gender
CVM type CVM location Aneurysm
Specified arter
1(1) 73,F C þ AV Lt.arm Lt.radial A
(2) Lt.brachial A
2(1) 50,F C þ AV Rt.arm-chest Rt.ulnal A
(2) Rt.radial A
Rt.ulnal A
Rt.AIOA
3 37,F CV Lt.leg Lt.popliteal A
4 68,F C þ AV Lt.groin-thigh Lt.CFA-DFA
Aorta
Lt.CIA
5 64,M AV pelvis Rt.IIA
6 55,F C þ AV Rt.arm Rt.brachial A
7 73,M AV pelvis Lt.IIA
8 28,M AV Rt.pararenal Rt.renal A
9 53,M AV Rt.calf-foot Rt.PTA
10 10,M C þ AV Rt.leg Rt.ATA
Rt.peroneal A
Rt.PTA
11 70,F C þ AV Rt.leg Rt.obturator A
Rt.SFA
12 33,F C þ AV Rt.forearm Rt.radial A
Rt.ulnal A
13 47,M C þ AV Rt.calf branches
14 28,M CV Lt.upper arm Lt.brachial A
C þ AV, Combined vascular defects þ Predominantly arteriovenous (AV
Predominantly AV shunting defects type; AIOA, anterior interosseous
CIA, common iliac artery; IIA, internal iliac artery; PTA, posterior t
artery; f, fusiform; s, saccular; w/w, taking a wait and watch approa
a The follow-up terms from the last operation.Of the eight patients (patients #7e#14) who were fol-
lowed up without surgery, recent aneurysm enlargement
was observed in two patients (patients #10 and #13); they
were under consideration for surgical treatment. All
patients survived, and none underwent limb amputation.
Model cases of CVM-associated aneurysm are presented
below.
A case of ruptured aneurysm (Patient 1)
A 73-year-old woman with a CVM that was classified as
a ‘combined vascular defect þ predominantly AV shunting
defects type’, had been conscious of the CVM in her left-
upper extremity since childhood. After her condition
was diagnosed 9 years previously, she discontinued her
hospital visits until the rupture of the aneurysm at her
left radial artery (Fig. 1(a)). She underwent emergency
aneurysmectomy with ligation of both inflow and outflow
vessels. An aneurysm that had also been discovered in her
left brachial artery was also discovered at that time, but
she had stopped visiting the hospital on her own. SheHeart
failure
Treatment
strategy
Follow-up
(month)
Indication
for surgeryy Size
(mm),
form
50 s no surgery 108 Rupture
10 s no surgery 82a Rupture
18 s no surgery 24 Rupture
8 s no surgery 15a rapid
enlargement
10 s
10 s
36 f no surgery 117 Enlargement,
for limb salvage
25 f yes surgery 21 Severe heart
failure
46 f w/w
45 f
50 s yes surgery 37 deteriorating
Heart failure
30 s no surgery 23 rupture
25 s no w/w 1
15 s no w/w 2
30 f no w/w 7
12 s no w/w 123
20 s
12 f
15 s no w/w 35
11 s
10 f no w/w 19
10 f
100 s no w/w 18
18 f no w/w 16
) shunting defects type; CV, Combined vascular defects type; AVS,
artery; CFA, common femoral artery; DFA, deep femoral artery;
ibial artery; ATA, anterior tibial artery; SFA, superficial femoral
ch.
Figure 1 Patient 1. a, Physical findings of the left forearm. Marked swelling and purpura were observed at the forearm (arrow).
b, Angiography of the left forearm at the time of first rupture. The aneurysm of the left brachial artery was recognized at this time
(arrow). c, Illustration of the surgery performed to treat the rupture of the brachial artery aneurysm. The aneurysm was isolated by
the ligation of inflow and outflow arteries.
520 J. Suzuki et al.presented again after 15 months with ruptured aneurysm
(Fig. 1(b) and (c)). Aneurysmorrhaphy and aneurysm isola-
tion were performed. No aneurysm recurrence occurred
thereafter.
A case of ruptured aneurysm (Patient 2)
A 50-year-old woman had a CVM in the rightupper extremity
since childhood. She had undergone surgical shunt closure
17 times at other hospitals. She experienced sudden
swelling of her right forearm immediately prior to the
admission to our hospital. After being diagnosed with
ruptured aneurysm in the right ulnar artery, she underwent
aneurysmectomy and AV shunt closure at our hospital. Six
months later, three new aneurysms developed in her right
forearm, and she subsequently received additional
aneurysmectomies.
A case of CVM-associated heart failure (Patient 4)
A 68-year-old woman with CVM that was classified as
a ‘combined vascular defects þ predominantly AV shunting-
defects type’, was diagnosed with CHF. The CVM was located
in her left thigh, and the increased shunt flowcomplicated theCHF. She had aneurysms at the abdominal aorta, left common
iliac artery, left common femoral artery (CFA) and left deep
femoral artery (DFA). Dilated left iliac and femoral veins were
also observed (Fig. 2(a) and (b)). Surgical disconnection of the
DFA from the CFA was simultaneously performed together
with CFA banding under blood pressure monitoring at the
ankle (Fig. 2(c)). After the surgery, the patient’s CHF
improved from 3rd to 2nd degree according to the NYHA
classification of cardiac performance, and her brain natri-
uretic peptide (BNP) level decreased from 552 to 246 pgml1.
One year later, she underwent additional endovascular
treatments in her left leg by using a sclerosing agent for the
nidus and the feeding vessels.A case of uncontrollable bleeding (Patient 6)
A 55-year-old woman with CVM that was classified as
a ‘combined vascular defects þ predominantly AV shunt-
ing defects type’, was admitted to our hospital because of
bleeding from the AVM at the top of her right finger. She
had an aneurysm at the right brachial artery (RBA).
Because the bleeding was difficult to control and the
aneurysm was large, she had undergone emergency
surgical aneurysmectomy with ligation of the RBA (Fig. 3).
Figure 2 Patient 4. a,b, Preoperative computed tomography
angiogram (a, frontal; b, from the left side). The congenital
vascular malformation located at the left thigh was mainly fed
through the aneurysm at the left deep femoral artery (DFA)
(arrow). Aneurysmal dilatation was recognized at the abdom-
inal aorta, left common iliac artery, left common femoral
(CFA), and left DFA. c, Photograph after DFA cutoff (stump;
black arrow)and CFA banding (white arrow). CFA banding was
performed to monitor ankle pressure. After the banding,
pulmonary arterial pressure and cardiac output decreased from
36 to 34 mmHg and 8 to 6 L/min, respectively.
Figure 3 Patient 6. a, Physical finding of the right hand upon
admission because of bleeding from an ulcerative lesion at the
top of the first digit. b, Angiography; 2 aneurysms were
recognized at the right brachial artery (arrow).
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the swelling of the CVM in her forearm and hand consid-
erably improved.Discussion
Only a few reports of extracranial CVM-associated aneu-
rysms are available, including the report of Akagi et al. on
six cases of KlippeleTrenaunay syndrome.2 Aneurysms
associated with CVM are not involved in either its clinical
classification4 or its treatment indications, as propounded
by Schobinger staging.5 Although the system of ref-
errals from other hospitals and clinics to our hospitalmightpredispose our results to some bias, the present study
suggests that aneurysm prevalence was 29% in patients with
extracranial CVM, indicating that aneurysm formation is not
a rare complication of CVM.
The pathogenesis of aneurysm formation can partly be
explained by the congenital weakness of the vessel walls6 in
CVM patients. In addition, the secondary reaction to the
abnormal haemodynamic stress caused by continuous high
pressure and high-flow turbulence might partly contribute
to aneurysm formation in CVM, especially in the presence
of AV shunts. The prevalence of aneurysm formation was
higher in patients with CVM and AV shunts than in those
without shunts. The reappearance of aneurysms shortly
after the resection in some patients with AV shunts may
support our suspicion.
We considered aneurysm rupture or enlargement as
indicator for the surgical treatment of CVM-complicated
aneurysms. The risk factors of aneurysm rupture in the
presence of CVM have not been clarified, and the aneurysm
size, shape and growth rate should be taken into account
while considering surgery. In this study, we reconfirmed
that saccular-form aneurysms tend to enlarge or rupture.
Surgery is not the basis for treatment, but is part of
a multidisciplinary approach for treating patients with AVM.
In general, a myriad number of AV shunts, ranging from
microscopic to macroscopic in size, may occur in patients
with CVM. Major surgery for CVM contains significant risks of
bleeding and associated complications.7 We restrict surgery
to CVM mainly for the treatment of accompanying lesions,
including aneurysms, bleeding and/or large AV fistula
causing CHF. Considering the possible need for repe-
ated treatment, minimally invasive techniques, such as
522 J. Suzuki et al.catheter embolisation and sclerotherapy, should be the
basis of treatment, and surgery should be minimally used.
Irrespective of the treatment procedure, use of repeated
condition-specific therapies is indispensable for CVM
patients. Rockman et al. reported that >70% of CVM
patients had already undergone initial therapies.8 In our
series, one patient underwent 17 surgical shunt ligations.
Mendel at al. have reported 12 recurrences in 17 cases of
surgically treated CVMs of the upper extremity.9 In another
report, 12 CVM patients were mainly treated with endo-
vascular embolisation, and eight experienced recurrence.10
Some patients in our series have not undergone any addi-
tional treatments, such as endovascular procedures, after
surgery. Although we never opine that endovascular treat-
ment is not necessary and that ‘wait and watch’ is the best
choice for CVM patients, we selected a ‘wait and watch
approach’ in most cases, taking into account the results of
previous reports.
Aggressive treatment for CVM in the limb may result in
critical limb ischaemia. In an emergency case (such as
patient #1) involving ligation of the brachial artery con-
necting to the ruptured aneurysm, a lateral branch of the
brachial artery might serve as an abnormal vessel feeding
the nidus. We preserved the vessel fearing limb loss and
eventually obtained a good long-term result. Ankle-
pressure measurement was an effective monitoring tool
for preventing ischaemic complications after major
artery ligation. In addition, skin-perfusion-pressure
measurement at distal sites with arterial compression
may also be useful for predicting limb prognosis after
arterial ligation.
There are some reports of CVM-associated CHF located
in the extremities or body trunk.3,8,11,12 In such cases,
endovascular embolisation procedures were mainly per-
formed for shunt closure with acceptable outcomes.
However, in patient #4 of the present study, large inflow
arteries and broad areas of AV shunt lesions led us to select
femoral-artery ligation and banding as the surgical proce-
dures to decrease the shunt flow, while avoiding necrosis,
which might occur with catheter embolisation or scle-
rotherapy in high-flow conditions. In this case, after
surgical closure of the large AV fistula, additional endo-
vascular therapy was also performed for the other feeding
vessels and the nidus.
We consider it necessary to search for the presence of
aneurysms upon initial consultation or to examine for
aneurysm formation during follow-up visits, especially in
patients with CVM classified as ‘predominantly AV shunting
defect type’ or ‘combined vascular defects þ pred-
ominantly AV shunting defects type’. Once an aneurysm is
detected, regular follow-up to check its growth is manda-
tory. As our study possibly indicates that saccular aneu-
rysms are likely to enlarge or rupture, such aneurysms
should be observed more carefully. In some cases, planned
preventive surgery is indicated before an aneurysm
emerges.Conclusion
Aneurysm is not a rare complication of extracranial CVM. In
CVM patients, it is important to treat CVM before an
aneurysm emerges. In addition to treatment for CVM,
regular screening for and appropriate management of
aneurysms in CVM patients are indispensable.
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